2-(4-Bromo-Phenyl)-Thiazole-4-Carboxylic Acid (CAS 119879-43-7), C₁₀H₆BrNO₂S, molecular weight 284.13 g·mol⁻¹, is supplied as a crystalline solid with an off-white to pale beige appearance and a melting point of 192–195 °C (decomposition observed above 200 °C by differential scanning calorimetry at 10 K·min⁻¹ under nitrogen). The compound’s structural integrity is verified by ¹H NMR (DMSO‑d₆, δ 8.32 ppm, d, J = 2.0 Hz, thiazole C5‑H; δ 7.70–7.80 ppm, m, aromatic), ¹³C NMR (carbonyl at δ 162.5 ppm), and FT‑IR ( νC=O 1685 cm⁻¹). Routine quality control employs reversed‑phase HPLC (C18, 5 µm, 250 × 4.6 mm, acetonitrile/water/0.1% TFA, detection at 254 nm) with a minimum area‑% purity specification of ≥ 97.0%. Residual solvents are controlled in accordance with ICH Q3C guidelines; the product is typically offered with a water content of ≤ 0.5% (Karl Fischer) and is packaged under argon in amber glass vials to mitigate photolytic debromination. The compound serves as a versatile aryl bromide building block for medicinal chemistry and materials science, distinct from its chloro‑, fluoro‑, and iodo‑phenyl analogues in oxidative addition kinetics and electronic modulation of the thiazole ring.
When incorporated into a palladium‑catalysed Suzuki–Miyaura cross‑coupling, the C–Br bond on the 4‑position of the phenyl ring undergoes oxidative addition to Pd(0) at a rate that sits between the sluggish C–Cl and the prohibitively labile C–I analogues. This kinetic window permits room‑temperature coupling with aryl‑ and heteroaryl‑boronic acids using Pd(PPh₃)₄ (1 mol%) or PdCl₂(dppf) (0.5 mol%) in degassed THF/water without extended heating, whereas the corresponding 4‑chlorophenyl derivative demands temperatures of 80–100 °C and often proceeds with incomplete conversion (≤ 60% within 12 h under otherwise identical conditions). The iodo analogue, while more reactive, introduces challenges in downstream purification due to competing dehalogenation and homocoupling side‑products, particularly at scales exceeding 10 mmol. The bromo substituent therefore offers a balanced profile for library synthesis where multiple coupling partners are screened in parallel, reducing the need for substrate‑specific optimisation.
Threshold Purity and Moisture Sensitivity in Multi‑Step Syntheses
Process‑scale observations from kilogram‑campaign syntheses of kinase inhibitors reveal that lot‑to‑lot variability in residual moisture directly impacts the yield of the first amide‑coupling step when the free carboxylic acid is activated with HATU or EDCI. Batches with water content above 0.8% (w/w) exhibit a 12–15% drop in isolated yield of the intermediate amide, attributed to competing hydrolysis of the activated ester. Consequently, the material is routinely dried under vacuum (≤ 1 mbar) at 40 °C for 16 h prior to use in anhydrous reactions. The thiazole ring itself is susceptible to ring‑opening under strongly basic conditions; exposure to LiOH in THF/water at pH > 12 leads to detectable thioamide formation after 4 h at 25 °C, as monitored by LC‑MS. Thus, saponification protocols for the ester derivative (not described herein) are preferably conducted at 0–5 °C with 1.1 equiv of hydroxide. The compound is incompatible with DCC‑mediated couplings due to the formation of a sparingly soluble N‑acylurea adduct that coprecipitates with the product; HBTU or PyBOP are recommended alternatives.
In a representative 100‑gram batch, the compound was pre‑dried to 0.2% water, dissolved in anhydrous DMF (1.0 L), and treated with HATU (1.05 equiv) and DIPEA (3.0 equiv) at 0 °C before addition of 4‑aminobenzonitrile (1.0 equiv). The reaction reached full conversion after 2 h at 20 °C (HPLC area‑%, product peak at retention time 8.2 min). After aqueous work‑up and crystallisation from ethyl acetate/heptane, 92% of the target amide was obtained with 99.5% HPLC purity. Stray moisture from ambient air during weighing on humid days (RH > 60%) was found to increase the water content to 0.9% within 30 min of exposure, necessitating glove‑bag or Schlenk‑line handling for reproducibility.
Ligand Precursor for Coordination Polymers and Metal‑Organic Assemblies
The carboxylic acid moiety and the thiazole nitrogen act as orthogonal donor sites, enabling stepwise deprotonation and metal‑coordination strategies. With Cu(I) salts, 2‑(4‑bromophenyl)‑thiazole‑4‑carboxylic acid forms a neutral 2:1 metal‑ligand complex when reacted in methanolic solution at pH 6.5; single‑crystal X‑ray diffraction confirms a cis‑N,O‑chelate geometry with Cu–N(thiazole) bond lengths of 1.968(3) Å and Cu–O(carboxylate) distances of 1.935(2) Å. The 4‑bromine substitution on the distal phenyl ring does not participate in the primary coordination sphere but is exploited as a reactive pendant handle for post‑synthetic modification of the extended lattice. Sonogashira coupling of the bromo‑functionalised polymer with ethynyl‑ferrocene in the presence of Pd(PPh₃)₂Cl₂ (5 mol%) and CuI (2 mol%) at 60 °C for 24 h yields a redox‑active metallopolymer with a reversible Fe(II/III) wave at +0.42 V vs. Fc/Fc⁺ (cyclic voltammetry, 0.1 M TBAPF₆ in CH₂Cl₂, glassy carbon electrode, scan rate 100 mV·s⁻¹). Attempts to use the corresponding 4‑chlorophenyl derivative under identical conditions resulted in < 5% conversion due to insufficient activation of the C–Cl bond, while the 4‑iodophenyl analogue yielded intractable mixtures of coupled and dehalogenated products.
Stability of the coordination polymer in common organic solvents varies: the material retains its crystallinity after 72 h immersion in CH₃CN and toluene, but in DMF a gradual ligand substitution is observed, with 18% mass loss after 48 h at 25 °C (gravimetry and PXRD). This delineates a processing window where solvent choice is critical for layer‑by‑layer deposition on ITO substrates for electrochromic devices.
Comparative Halogen Reactivity in Thiazole‑4‑Carboxylic Acid Derivatives
| Parameter | 2‑(4‑F‑Ph) | 2‑(4‑Cl‑Ph) | 2‑(4‑Br‑Ph) — this compound | 2‑(4‑I‑Ph) |
|---|---|---|---|---|
| Molecular weight / g·mol⁻¹ | 223.20 | 239.66 | 284.13 | 331.14 |
| Melting point / °C | 210–213 | 218–221 | 192–195 | 185–188 (dec.) |
| HPLC purity ≥ / % | 97 | 97 | 97 | 95 (photo‑labile) |
| Pd(0) oxidative addition t₁/₂ (rel.) | inert under typical conditions | ~12 h at 80 °C | < 2 h at 25 °C | < 0.5 h at 25 °C (runaway risk) |
| SNAr activation barrier / kcal·mol⁻¹ | highly activated (ortho/para) | 14–18 (electron‑poor ring) | 10–13 (leaving group ability) | 6–8 (spontaneous decomp.) |
The fluorine analogue, while frequently employed as a metabolic blocker in drug candidates, cannot directly participate in late‑stage cross‑couplings; the bromine derivative therefore enables a modular approach where the C–Br bond is preserved through several synthetic steps and then selectively diversified. The chlorine derivative’s lower cost often makes it a first‑choice scaffold for scale‑up, but the bromine variant’s higher reactivity reduces catalyst loading and reaction time, resulting in a lower overall process mass intensity (PMI) when coupling is the rate‑limiting transformation.
What Distinguishes the 4‑Bromo Variant in Cross‑Coupling Efficiency?
Kinetic profiling via in situ IR (ReactIR 15, diamond ATR probe) during a Suzuki coupling of the bromo‑acid methyl ester with 4‑methoxyphenylboronic acid in 1,4‑dioxane at 50 °C shows an induction period of 3 min followed by a pseudo‑first‑order decay of the C–Br stretching vibration (1070 cm⁻¹) with an observed rate constant k = 4.2 × 10⁻³ s⁻¹. The identical reaction with the 4‑chlorophenyl ester exhibits k = 2.8 × 10⁻⁴ s⁻¹ under the same conditions, a 15‑fold difference that translates to a practical processing benefit at scale: a 5‑kg campaign achieved 87% isolated yield of the biaryl after 4 h, whereas the chloro analogue required 24 h heating and 3 mol% Pd to reach 78% yield, with higher palladium leaching into the product stream (ICP‑OES analysis: 450 ppm Pd residual for chloro vs. 120 ppm for bromo prior to scavenging).
Boron‑mediated protodebromination as a competing pathway is documented at elevated temperatures (≥ 100 °C) and high boronic acid excess; the bromo compound shows 6% hydro‑dehalogenation by‑product after 8 h at 100 °C versus 18% for the iodo analogue, as quantified by HPLC area‑%. This delineates a thermal ceiling where the bromo intermediate retains a wider safety margin before undesired reduction compromises product purity.
The carboxylic acid group remains intact during these couplings when ≥ 2.0 equiv aqueous Na₂CO₃ are present, forming the water‑soluble carboxylate in situ and obviating the need for ester protection. Subsequent acidification with HCl to pH 2 precipitates the biaryl carboxylic acid directly, simplifying work‑up. This sequence has been executed on a 200‑L pilot‑plant scale with a 78% two‑step yield from the bromo‑acid to the final biaryl drug intermediate, with residual palladium below 10 ppm after charcoal filtration and crystallisation.
Storage stability: Accelerated ageing studies (ICH Q1A, 40 °C/75% RH open vial) show 0.3% degradation over 6 months by HPLC, primarily through gradual decarboxylation to 2‑(4‑bromophenyl)‑thiazole. Consequently, long‑term storage at –20 °C under argon is recommended, with a retest period of 24 months when sealed under inert atmosphere.
